NCT06636734 2026-02-11
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Emory University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT04227509 2025-12-31
Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Seoul National University Hospital
Phase 2 Completed
NCT07129772 2025-09-04
Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma
The University of Hong Kong
Phase 2 Not yet recruiting
NCT03544099 2023-04-11
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA
National Health Research Institutes, Taiwan
Phase 2 Terminated
NCT04825990 2022-04-07
POINT
Gruppo Oncologico del Nord-Ovest
Phase 2 Recruiting